Julia Foster

777 total citations
17 papers, 360 citations indexed

About

Julia Foster is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Julia Foster has authored 17 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Genetics. Recurrent topics in Julia Foster's work include Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Julia Foster is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Julia Foster collaborates with scholars based in United States, Canada and Bangladesh. Julia Foster's co-authors include Amir T. Fathi, Martha Wadleigh, Philip C. Amrein, Richard M. Stone, David P. Steensma, Andrew M. Brunner, Daniel J. DeAngelo, Areej El‐Jawahri, Jennifer S. Temel and Thomas W. LeBlanc and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Julia Foster

14 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Foster United States 9 212 155 152 140 55 17 360
Veena Fauble United States 9 77 0.4× 168 1.1× 53 0.3× 61 0.4× 112 2.0× 25 295
Rocío Cárdenas‐Cardós Mexico 11 135 0.6× 38 0.2× 88 0.6× 131 0.9× 41 0.7× 41 344
Ching-Hon Pui United States 10 397 1.9× 169 1.1× 96 0.6× 285 2.0× 30 0.5× 10 517
Nicole Wong Doo Australia 10 65 0.3× 41 0.3× 124 0.8× 62 0.4× 43 0.8× 29 317
R. Rutledge United States 4 270 1.3× 212 1.4× 77 0.5× 131 0.9× 35 0.6× 12 345
Patricia Alcasabas United States 5 214 1.0× 24 0.2× 93 0.6× 248 1.8× 34 0.6× 6 408
Britt‐Marie Frost Sweden 11 166 0.8× 95 0.6× 81 0.5× 126 0.9× 19 0.3× 26 321
G Kardos Hungary 9 144 0.7× 226 1.5× 40 0.3× 97 0.7× 46 0.8× 28 391
Deepam Pushpam India 10 64 0.3× 66 0.4× 91 0.6× 52 0.4× 25 0.5× 74 272
P. Talley United Kingdom 5 112 0.5× 119 0.8× 85 0.6× 34 0.2× 73 1.3× 6 296

Countries citing papers authored by Julia Foster

Since Specialization
Citations

This map shows the geographic impact of Julia Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Foster more than expected).

Fields of papers citing papers by Julia Foster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Foster. The network helps show where Julia Foster may publish in the future.

Co-authorship network of co-authors of Julia Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Foster. A scholar is included among the top collaborators of Julia Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Foster. Julia Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sabir, Sharjeel, Julia Foster, J.M. Ortega, et al.. (2025). Increasing length board use in a neonatal intensive care unit: a quality improvement initiative. Journal of Perinatology. 46(3). 479–484.
2.
Shukla, Rohit, et al.. (2023). Improving access to vision rehabilitation care: implementation of the South East Ontario Vision Rehabilitation Service. Canadian Journal of Ophthalmology. 59(5). e471–e478. 3 indexed citations
3.
Eden, Karen, et al.. (2022). Increased quantity and diversity of patient referrals following the introduction of a novel vision rehabilitation model. British Journal of Visual Impairment. 41(4). 980–989.
4.
5.
Nardi, Valentina, Steven L. McAfee, Paola Dal Cin, et al.. (2022). Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy. The Oncologist. 27(2). 82–86. 4 indexed citations
6.
Hobbs, Gabriela, Cansu Cimen Bozkus, Erin Moshier, et al.. (2021). PD-1 inhibition in advanced myeloproliferative neoplasms. Blood Advances. 5(23). 5086–5097. 27 indexed citations
7.
Hobbs, Gabriela, Cansu Cimen Bozkus, Martha Wadleigh, et al.. (2020). Results of a Phase II Study of PD-1 Inhibition in Advanced Myeloproliferative Neoplasms. Blood. 136(Supplement 1). 14–15. 7 indexed citations
8.
El‐Jawahri, Areej, Thomas W. LeBlanc, Jason A. Webb, et al.. (2020). Multisite randomized trial of integrated palliative and oncology care for patients with acute myeloid leukemia (AML).. Journal of Clinical Oncology. 38(15_suppl). 12000–12000. 14 indexed citations
9.
Nardi, Valentina, Nora Ku, Matthew J. Frigault, et al.. (2020). Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement. Blood Advances. 4(1). 106–111. 22 indexed citations
10.
Kasbekar, Monica, Valentina Nardi, Paola Dal Cin, et al.. (2020). Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia. Blood Advances. 4(13). 3136–3140. 28 indexed citations
11.
Fathi, Amir T., Alexander E. Perl, Mark J. Levis, et al.. (2020). Concurrent FLT3 Inhibitor and IDH Inhibitor Therapy in Patients with Acute Myeloid Leukemia (AML). Blood. 136(Supplement 1). 11–12. 5 indexed citations
12.
El‐Jawahri, Areej, Gregory A. Abel, Lara Traeger, et al.. (2019). Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 33(10). 2393–2402. 43 indexed citations
13.
El‐Jawahri, Areej, Harry VanDusen, Lara Traeger, et al.. (2018). Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia. The Oncologist. 24(2). 247–254. 52 indexed citations
14.
Abel, Gregory A., Amir T. Fathi, David P. Steensma, et al.. (2017). Perceptions of prognosis and treatment risk in older patients with acute myeloid leukemia (AML).. Journal of Clinical Oncology. 35(31_suppl). 43–43. 2 indexed citations
15.
Fathi, Amir T., Daniel J. DeAngelo, Kristen E. Stevenson, et al.. (2016). Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia. Cancer. 122(15). 2379–2388. 22 indexed citations
16.
El‐Jawahri, Areej, Gregory A. Abel, David P. Steensma, et al.. (2015). Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia. Cancer. 121(16). 2840–2848. 105 indexed citations
17.
Attar, Eyal C., Philip C. Amrein, James W. Fraser, et al.. (2013). Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Leukemia Research. 37(9). 1016–1020. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veena Fauble Breakdown of academic impact, for papers by Rocío Cárdenas‐Cardós Breakdown of academic impact, for papers by Ching-Hon Pui Breakdown of academic impact, for papers by Nicole Wong Doo Breakdown of academic impact, for papers by R. Rutledge Breakdown of academic impact, for papers by Patricia Alcasabas Breakdown of academic impact, for papers by Britt‐Marie Frost Breakdown of academic impact, for papers by G Kardos Breakdown of academic impact, for papers by Deepam Pushpam Breakdown of academic impact, for papers by P. Talley
Rankless by CCL
2026